Be part of the knowledge.™

New Drug for Diabetic Patients in Phase 2 Trials

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. Berkowitz, President and CEO of Alteon, Inc. discusses a new drug that they are developing for diabetic patients.

Noah Berkowitz, MD

Noah Berkowitz, MD

Shira Johnson, MD

Shira Johnson, MD

Recommended

Details

Presenters

Overview
Dr. Berkowitz, President and CEO of Alteon, Inc. discusses a new drug that they are developing for diabetic patients.

Noah Berkowitz, MD

Noah Berkowitz, MD

Shira Johnson, MD

Shira Johnson, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

FCS and SHTG: Are We Meeting the Need?

CME/CE Broadcast Replay

Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care

New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure

HF Management for Patients with Comorbid Conditions

Level Up Your Skills: Tailoring Management of HF

Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow

Personalizing Care Within the RCC Treatment Paradigm

Understanding hypertrophic cardiomyopathy and recent guidelines